Reconsidering the role of plasma pgRNA in NUC-treated CHB: Stratified biomarker interpretation and the limits of current assays: Letter to the editor on "Longitudinal profile of plasma pregenomic RNA in patients with chronic hepatitis B infection on long-term nucleoside analogues and its interaction with clinical parameters"

重新审视血浆 pgRNA 在 NUC 治疗的慢性乙型肝炎中的作用：分层生物标志物解读和当前检测方法的局限性：致编辑的信，主题为“长期接受核苷类似物治疗的慢性乙型肝炎感染患者血浆前基因组 RNA 的纵向变化及其与临床参数的相互作用”。